Chen Ping, Hübner Wolfgang, Riviere Kareen, Liu Yu-Xin, Chen Benjamin K
Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, NY 10029, USA.
Virology. 2006 May 25;349(1):1-12. doi: 10.1016/j.virol.2006.02.022. Epub 2006 Mar 23.
Murine fibroblasts expressing viral receptors and human cyclin T1 allow HIV-1 entry and viral gene expression but do not support efficient assembly. A chimeric HIV-1 carrying a non-homologous matrix (MA) from murine leukemia virus in place of HIV-1 MA can assemble efficiently in murine cells, yet has poor infectivity. Here, we assess the ability of a homologous MA from SIV MAC239 to complement assembly and infection in chimeric viruses designated SHIV(MA). The resulting SHIV(MA) chimeras produce more virus than native HIV-1 when transfected into murine cells. SHIV(MA) exhibits cell-type-specific replication in human T cell lines, replicating well in MT4 cells and poorly in Jurkat cells due to an incompatibility with the HIV-1 Env. The infectivity defects of SHIV(MA) are rescued by pseudotyping with VSV-G but not by truncation of the cytoplasmic tail of Env. Passage of SHIV(MA) in Jurkat cells produces variants with improved Env incorporation and improved replication in Jurkat but not in 3T3 TXC cells. The results indicate that cell-type-specific, or species-specific, host factors interact with MA to modulate the efficiency of assembly and its compatibility with Env. With additional selection, SIV/HIV-1 chimeras may be useful for the development of murine models of lentiviral infection.
表达病毒受体和人细胞周期蛋白T1的鼠成纤维细胞可使HIV-1进入并进行病毒基因表达,但不支持高效组装。携带来自鼠白血病病毒的非同源基质(MA)以取代HIV-1 MA的嵌合HIV-1能够在鼠细胞中高效组装,但其感染性较差。在此,我们评估来自SIV MAC239的同源MA在命名为SHIV(MA)的嵌合病毒中补充组装和感染的能力。当转染到鼠细胞中时,产生的SHIV(MA)嵌合体比天然HIV-1产生更多病毒。SHIV(MA)在人T细胞系中表现出细胞类型特异性复制,由于与HIV-1 Env不兼容,在MT4细胞中复制良好,而在Jurkat细胞中复制较差。SHIV(MA)的感染性缺陷可通过用VSV-G进行假型化来挽救,但不能通过截断Env的细胞质尾巴来挽救。SHIV(MA)在Jurkat细胞中传代产生变体,其Env整合得到改善,在Jurkat细胞中的复制得到改善,但在3T3 TXC细胞中则不然。结果表明,细胞类型特异性或物种特异性宿主因子与MA相互作用,以调节组装效率及其与Env的兼容性。通过进一步筛选,SIV/HIV-1嵌合体可能有助于慢病毒感染鼠模型的开发。